What is Ironwood Pharmaceuticals's investing cash flow?

Ironwood Pharmaceuticals (IRWD) reported investing cash flow of $0 in Q4 2025.

What is the long-term trend for Ironwood Pharmaceuticals's investing cash flow?

Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's investing cash flow has grown at a -42.8% compound annual growth rate (CAGR), from -$326.75K to -$35K.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ironwood Pharmaceuticals IRWD Investing Cash Flow

Investing Cash Flow at other companies

Bausch Health CompaniesBHC

-$139M-6.9%

ArdelyxARDX

-$10M-451%

Eton Pharmaceuticals, Inc.ETON

-$15.08M—

Rigel PharmaceuticalsRIGL

-$7.98M+24.4%

ANI PharmaceuticalsANIP

-$11.32M+42.9%

Catalyst PharmaceuticalCPRX

-$27K—

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's investing cash flow?: Ironwood Pharmaceuticals (IRWD) reported investing cash flow of $0 in Q4 2025.
What is the long-term trend for Ironwood Pharmaceuticals's investing cash flow?: Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's investing cash flow has grown at a -42.8% compound annual growth rate (CAGR), from -$326.75K to -$35K.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.